Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics

被引:45
|
作者
Mooij, Miriam G. [1 ,2 ]
Nies, Anne T. [3 ,4 ]
Knibbe, Catherijne A. J. [5 ,6 ]
Schaeffeler, Elke [3 ,4 ]
Tibboel, Dick [1 ,2 ]
Schwab, Matthias [3 ,7 ]
de Wildt, Saskia N. [1 ,2 ]
机构
[1] Erasmus MC Sophia Childrens Hosp, Intens Care, Room Sp 3458,Wytemaweg 80,POB 2060, NL-3000 CB Rotterdam, Netherlands
[2] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Room Sp 3458,Wytemaweg 80,POB 2060, NL-3000 CB Rotterdam, Netherlands
[3] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[4] Univ Tubingen, Tubingen, Germany
[5] Leiden Acad Ctr Res Pharmacol, Fac Sci, Leiden, Netherlands
[6] St Antonius Hosp, Hosp Pharm & Clin Pharmacol, Nieuwegein, Netherlands
[7] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany
关键词
MESSENGER-RNA EXPRESSION; TACROLIMUS DOSING REQUIREMENTS; SINGLE-DOSE PHARMACOKINETICS; P-GLYCOPROTEIN EXPRESSION; FAMILIAL HYPERCHOLESTEROLEMIA; POPULATION PHARMACOKINETICS; INTERINDIVIDUAL VARIABILITY; GENETIC POLYMORPHISMS; METABOLIZING-ENZYMES; DOSAGE REQUIREMENTS;
D O I
10.1007/s40262-015-0328-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Membrane transporters play an essential role in the transport of endogenous and exogenous compounds, and consequently they mediate the uptake, distribution, and excretion of many drugs. The clinical relevance of transporters in drug disposition and their effect in adults have been shown in drug-drug interaction and pharmacogenomic studies. Little is known, however, about the ontogeny of human membrane transporters and their roles in pediatric pharmacotherapy. As they are involved in the transport of endogenous substrates, growth and development may be important determinants of their expression and activity. This review presents an overview of our current knowledge on human membrane transporters in pediatric drug disposition and effect. Existing pharmacokinetic and pharmacogenetic data on membrane substrate drugs frequently used in children are presented and related, where possible, to existing ex vivo data, providing a basis for developmental patterns for individual human membrane transporters. As data for individual transporters are currently still scarce, there is a striking information gap regarding the role of human membrane transporters in drug therapy in children.
引用
收藏
页码:507 / 524
页数:18
相关论文
共 50 条
  • [31] Membrane transporters in drug development and as determinants of precision medicine
    Galetin, Aleksandra
    Brouwer, Kim L. R.
    Tweedie, Donald
    Yoshida, Kenta
    Sjostedt, Noora
    Aleksunes, Lauren
    Chu, Xiaoyan
    Evers, Raymond
    Hafey, Michael J.
    Lai, Yurong
    Matsson, Par
    Riselli, Andrew
    Shen, Hong
    Sparreboom, Alex
    Varma, Manthena V. S.
    Yang, Jia
    Yang, Xinning
    Yee, Sook Wah
    Zamek-Gliszczynski, Maciej J.
    Zhang, Lei
    Giacomini, Kathleen M.
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (04) : 255 - 280
  • [32] Membrane transporters in drug development and as determinants of precision medicine
    Aleksandra Galetin
    Kim L. R. Brouwer
    Donald Tweedie
    Kenta Yoshida
    Noora Sjöstedt
    Lauren Aleksunes
    Xiaoyan Chu
    Raymond Evers
    Michael J. Hafey
    Yurong Lai
    Pär Matsson
    Andrew Riselli
    Hong Shen
    Alex Sparreboom
    Manthena V. S. Varma
    Jia Yang
    Xinning Yang
    Sook Wah Yee
    Maciej J. Zamek-Gliszczynski
    Lei Zhang
    Kathleen M. Giacomini
    Nature Reviews Drug Discovery, 2024, 23 : 255 - 280
  • [33] Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction-Commentary Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction
    Mao, Qingcheng
    Lai, Yurong
    Wang, Joanne
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (05) : 561 - 566
  • [34] Pharmacogenetics of drug transporters in modulating imatinib disposition and treatment outcomes in chronic myeloid leukemia and gastrointestinal stromal tumor patients
    Chen, Sylvia
    Sutiman, Natalia
    Chowbay, Balram
    PHARMACOGENOMICS, 2016, 17 (17) : 1941 - 1955
  • [35] Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
    Camille Tron
    Florian Lemaitre
    Céline Verstuyft
    Antoine Petitcollin
    Marie-Clémence Verdier
    Eric Bellissant
    Clinical Pharmacokinetics, 2019, 58 : 593 - 613
  • [36] Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
    Tron, Camille
    Lemaitre, Florian
    Verstuyft, Celine
    Petitcollin, Antoine
    Verdier, Marie-Clemence
    Bellissant, Eric
    CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 593 - 613
  • [37] Pharmacogenetics and drug development
    Reiser, H
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 417 - 427
  • [38] Pharmacogenetics in drug development
    Becquemont, L.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2011, 15 (05): : 156 - 160
  • [39] Pediatric Pharmacokinetics Human Development and Drug Disposition
    Funk, Ryan S.
    Brown, Jacob T.
    Abdel-Rahman, Susan M.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2012, 59 (05) : 1001 - +
  • [40] Pharmacogenetics in drug development
    McCarthy, AD
    Kennedy, JL
    Middleton, LT
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1460) : 1579 - 1588